Diagnostic Approach to Left Ventricular Hypertrophy (LVH)
The diagnosis of LVH requires a multimodality approach with echocardiography as the cornerstone diagnostic test, supplemented by electrocardiography and, when necessary, cardiac magnetic resonance imaging (CMR). 1, 2
Primary Diagnostic Tests
Echocardiography
- First-line imaging modality for LVH diagnosis 1, 2, 3
- Diagnostic criteria:
- LV wall thickness ≥15 mm in one or more myocardial segments in adults
- For first-degree relatives of patients with HCM: LV wall thickness ≥13 mm
- For children: LV wall thickness >2 standard deviations above predicted mean (z-score >2) 2
- Comprehensive assessment should include:
12-Lead Electrocardiography
- Recommended for all patients with suspected LVH 4, 2
- Common ECG findings in LVH:
- Increased QRS voltage
- ST-T wave abnormalities
- Left axis deviation
- Left atrial abnormality
- QRS prolongation 4
- ECG is abnormal in 75-95% of patients with HCM but has lower sensitivity than imaging 5
- Common ECG criteria include:
- Cornell voltage criteria
- Sokolow-Lyon index
- Cornell voltage product 6
Advanced Imaging
Cardiovascular Magnetic Resonance (CMR)
- Indicated when:
- CMR advantages:
- Superior spatial resolution
- Sharp contrast between blood and myocardium
- Tomographic imaging of entire LV myocardium
- Late gadolinium enhancement (LGE) to detect myocardial fibrosis 1
- In one study, 6% of patients with suspected HCM were identified with increased LV wall thickness by CMR but not by echocardiography 1
Diagnostic Algorithm
Initial Assessment:
- 12-lead ECG to detect voltage criteria and associated abnormalities
- Comprehensive transthoracic echocardiography
If Echocardiography is Diagnostic:
- LV wall thickness ≥15 mm (adults) or z-score >2 (children)
- Proceed with risk stratification and management
If Echocardiography is Inconclusive:
- Proceed to CMR imaging for:
- Better visualization of areas not well seen on echo (anterolateral wall, apex)
- More precise measurement of wall thickness
- Assessment of myocardial fibrosis 1
- Proceed to CMR imaging for:
Additional Testing:
Special Considerations
ECG Limitations
- ECG has lower sensitivity (6-50%) compared to imaging (85-100%) 7
- Sensitivity decreases in obese patients 7
- ECG criteria may be affected by:
- Left bundle branch block (LBBB)
- Right bundle branch block (RBBB)
- Left anterior fascicular block 4
Distinguishing Primary vs. Secondary LVH
- Assess for other causes of LVH:
Common Pitfalls to Avoid
- Relying solely on ECG for diagnosis: ECG has limited sensitivity despite being a useful screening tool 7, 6
- Inadequate echocardiographic views: Multiple views including apical views are required to detect all patterns of hypertrophy 2
- Missing apical hypertrophy: This variant may be difficult to visualize with echocardiography but is evident with CMR 1
- Using dobutamine for stress testing: This can exacerbate obstruction and is not recommended in suspected HCM 3
- Failure to distinguish physiologic from pathologic hypertrophy: Athletic heart vs. HCM requires careful evaluation 2
Follow-up Recommendations
- Repeat echocardiography every 1-2 years in confirmed HCM 3
- Annual 12-lead ECG to evaluate for asymptomatic changes in conduction or rhythm 5, 3
- For family members of HCM patients: screening with ECG and echocardiography according to age-specific protocols 1, 2
By following this systematic approach, LVH can be accurately diagnosed, allowing for appropriate risk stratification and management to reduce morbidity and mortality.